Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | LSS | P48449 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10974028 | 1.00 | CYP1A2 (0.52) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL28500525 | 0.98 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL19125970 | 0.98 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL19125591 | 0.98 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL10772877 | 0.98 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL10429807 | 0.93 | CYP1A2 (0.46) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL8218778 | 0.93 | CYP1A2 (0.46) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL10486006 | 0.93 | CYP1A2 (0.46) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL10704696 | 0.93 | CYP1A2 (0.46) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL2901914 | 0.92 | CYP1A2 (0.61) | CYP1A2HTTLMNAMAPK1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225471-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | Hitachi Zosen Inova AG (CH) | 2023-08-16 | — | — | EP | claimed |
| WO-2022079004-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | HITACHI ZOSEN INOVA AG (CH) | 2022-04-21 | — | — | WO | claimed |
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | claimed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | claimed |
| JP-56140944-A | — | — | None | — | — | JP | disclosed |
| EP-4225471-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | Hitachi Zosen Inova AG (CH) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022079004-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | HITACHI ZOSEN INOVA AG (CH) | 2022-04-21 | — | — | WO | disclosed |
| US-20170207486-A1 | ELECTROLYTES FOR LITHIUM TRANSITION METAL PHOSPHATE BATTERIES | BASF CORPORATION (US) | 2017-07-20 | — | — | US | disclosed |
| CN-102918452-B | Liquid crystal display device | SHARP KK | 2015-03-04 | — | — | CN | disclosed |
| EP-2579091-A1 | LIQUID CRYSTAL DISPLAY DEVICE | Sharp Kabushiki Kaisha (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130083278-A1 | LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2013-04-04 | — | — | US | disclosed |
| US-7736533-B2 | Liquid crystal composition, liquid crystal device, reflective display material and light modulating material | FUJIFILM CORPORATION (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20090098314-A1 | Liquid crystal composition, liquid crystal device, reflective display material and light modulating material | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | disclosed |
| CN-1829786-A | Chroman derivative and liquid-crystal composition containing the compound | DAINIPPON INK & CHEMICALS (JP) | 2006-09-06 | — | — | CN | disclosed |
| EP-0422958-B1 | Dicyclohexylethylene derivatives | CHISSO CORP (JP) | 1994-04-27 | — | — | EP | disclosed |
| EP-0422958-A1 | Dicyclohexylethylene derivatives | Chisso Corporation (JP) | 1991-04-17 | — | — | EP | disclosed |
| JP-S56140944-A | CYCLOHEXYLMETHYL PHENYL ETHER DERIVATIVE | HITACHI LTD | 1981-11-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | CLSPN, LMAN2, RPN2 | CYP1A2 4174/4885HTT 4781/4885LMNA 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.